In multiple sclerosis, exogenous IFN-β provides durable disease-modifying benefits within the CNS, whereas IFN-γ is associated with relapse biology, highlighting tissue-dependent directionality [89]. This evidence concerns the gene IFNG and multiple sclerosis.